Please Wait
Applying Filters...
menu
    • menu
    LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.

    Virtual Booth

    Contact Supplier

    Sharp is a leader in commercial packaging, clinical services, and sterile manufacturing.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-04-20

    Virtual Booth

    An Enquiry

    As a CDMO, Mikart offers integrated CDMO services for Solid Dose & Non-sterile Liquid formulations.

    Virtual Booth

    Contact Supplier

    Trusted Global CDMO Partner Delivering End-to-End Pharma Manufacturing & Development Solutions.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    An Enquiry

    Menu

    Levomenthol

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    MARKET PLACE

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    CBD Life Sciences Inc. Unveils CBD Flavored Vapes
    CBD Life Sciences Inc. Unveils CBD Flavored Vapes

    12 May 2026

    // ACCESSWIRE

    https://www.accessnewswire.com/newsroom/en/healthcare-and-pharmaceutical/cbd-life-sciences-inc.-cbdl-announces-launch-of-cbd-flavored-vapes-1166042

    ACCESSWIRE
    12 May 2026
    Share Share
    FDA Expands Market Access, Authorizes New ENDS Products
    FDA Expands Market Access, Authorizes New ENDS Products

    05 May 2026

    // FDA

    https://www.fda.gov/news-events/press-announcements/fda-expands-market-access-authorizes-new-ends-products

    FDA
    05 May 2026
    Share Share
    FDgard® shows Excellent Safety And Tolerability Profile for Functional Dyspepsia
    FDgard® shows Excellent Safety And Tolerability Profile for Functional Dyspepsia

    28 Oct 2019

    // PR NEWS WIRE

    https://www.prnewswire.com/news-releases/in-the-longest-running-post-marketing-surveillance-study-of-its-type-data-at-24-months-on-fdgard-presented-at-the-american-college-of-gastroenterology-acg-annual-meeting-confirms-excellent-safety-and-tolerability-profile-of--300946011.html

    PR NEWS WIRE
    28 Oct 2019
    Share Share
    Enforcement Report - Week of May 30, 2018
    Enforcement Report - Week of May 30, 2018

    29 May 2018

    // FDA

    https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-may-30-2018-1527659653.pdf

    FDA
    29 May 2018
    Share Share
    Enforcement Report - Week of March 1, 2017
    Enforcement Report - Week of March 1, 2017

    01 Mar 2017

    // FDA

    https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-march-1-2017-1488363970.pdf

    FDA
    01 Mar 2017
    Share Share
    200 out of 500 combinations examined have been found irrational: Govt sources
    200 out of 500 combinations examined have been found irrational: Govt sources

    17 Nov 2016

    // Veena Mani BUSINESS STANDARD

    http://www.business-standard.com/article/companies/200-out-of-500-combinations-examined-have-been-found-irrational-govt-sources-116111601364_1.html

    Veena Mani BUSINESS STANDARD
    17 Nov 2016
    Share Share
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.